LendingTree TREE Rallies 135 as Bulls Target 3849 20260514 Dillards DDS Flat at 53322 Consolidation Continues 20260514 NextDecade Corporation NEXT Stock Analysis 094 Gain What to Watch 20260514 Why NextNav NNAVW Just Dropped 375 What to Watch 20260518 MPTI Q1 2026 Earnings EPS Beats Estimates by 113 Driving Positive Stock Reaction Fintech Firm Mercury Hits 52 Billion Valuation After Funding Round Up 49 in 14 Months DoorDash DASH Q1 2026 Earnings Why the Beat Matters NBR Q1 2026 Earnings EPS Surprise of Nearly 40 Fails to Lift Stock as Revenue Uncertainty Lingers FutureProofing Additive Manufacturing Intellectual Property Security in Decentralized Production Ethereums SecondPlace Status May Face Challenges by 2030 Analysts Suggest Kevin Hassett Highlights Surge in Credit Card Spending Amid Rising Delinquencies and Farm Bankruptcies Value Stocks Position for Indias Growth Cycle Autos Energy Recycling Solar Love Factually Dating Startups Target Fake Profiles with Verified Identity Solutions RBIs 5 Billion FX Swap Oversubscribed Nearly Twofold Amid Rupee Defense Jiayin Group Inc Q4 2024 Earnings EPS of 523 Reported Stock Declines 87 Ivanhoe Electric Q1 2026 Earnings WiderThanExpected Loss as Exploration Continues ACTU Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase AEON Q4 2025 Earnings Deep EPS Miss Amid PreRevenue Stage YPF Q4 2025 Earnings Massive Reported Loss Despite Positive Stock Movement Vestas Wind Systems Shares Decline After Margins Guidance Disappoints Taiwan Chip Stocks Rise on Nvidias 150 Billion Spending Commitment China Chip Firms Decline Market Update Highlights Zimmer Biomet AnheuserBusch InBev and Viatris Bernstein Initiates Coverage on Six Indian Pharma Stocks Highlights AI and Innovation as Key Drivers Trump Pressures Bank of America and JPMorgan Over Alleged Conservative Discrimination ZBH BUD VTRS Stocks See Mixed Trading in Latest Market Session San Francisco Giants GM Points Finger at Rookie Manager Amid Franchise Concerns Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses